nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CHRM3—Carbachol—glaucoma	0.107	0.138	CbGbCtD
Fesoterodine—CHRM3—Pilocarpine—glaucoma	0.0996	0.128	CbGbCtD
Fesoterodine—CHRM1—Carbachol—glaucoma	0.0932	0.12	CbGbCtD
Fesoterodine—CHRM1—Pilocarpine—glaucoma	0.0867	0.111	CbGbCtD
Fesoterodine—CHRM2—Carbachol—glaucoma	0.086	0.11	CbGbCtD
Fesoterodine—CHRM2—Pilocarpine—glaucoma	0.0799	0.103	CbGbCtD
Fesoterodine—CYP2D6—Carteolol—glaucoma	0.0384	0.0493	CbGbCtD
Fesoterodine—CYP2D6—Betaxolol—glaucoma	0.026	0.0333	CbGbCtD
Fesoterodine—CYP2D6—Methazolamide—glaucoma	0.0197	0.0253	CbGbCtD
Fesoterodine—CYP3A4—Pilocarpine—glaucoma	0.0185	0.0238	CbGbCtD
Fesoterodine—ABCB1—Timolol—glaucoma	0.0178	0.0228	CbGbCtD
Fesoterodine—CYP2D6—Timolol—glaucoma	0.0167	0.0215	CbGbCtD
Fesoterodine—ABCB1—Clonidine—glaucoma	0.0151	0.0194	CbGbCtD
Fesoterodine—CYP3A4—Brinzolamide—glaucoma	0.0145	0.0187	CbGbCtD
Fesoterodine—CYP2D6—Clonidine—glaucoma	0.0142	0.0183	CbGbCtD
Fesoterodine—CYP3A4—Dorzolamide—glaucoma	0.014	0.018	CbGbCtD
Fesoterodine—CYP3A4—Methazolamide—glaucoma	0.0125	0.0161	CbGbCtD
Fesoterodine—CYP3A4—Acetazolamide—glaucoma	0.01	0.0128	CbGbCtD
Fesoterodine—CYP3A4—Clonidine—glaucoma	0.00905	0.0116	CbGbCtD
Fesoterodine—Nervous system disorder—Brimonidine—glaucoma	0.000376	0.0018	CcSEcCtD
Fesoterodine—Chest pain—Brinzolamide—glaucoma	0.000376	0.0018	CcSEcCtD
Fesoterodine—Palpitations—Pilocarpine—glaucoma	0.000375	0.00179	CcSEcCtD
Fesoterodine—Tachycardia—Brimonidine—glaucoma	0.000374	0.00179	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000374	0.00179	CcSEcCtD
Fesoterodine—Dry mouth—Dorzolamide—glaucoma	0.000374	0.00179	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000373	0.00178	CcSEcCtD
Fesoterodine—Skin disorder—Brimonidine—glaucoma	0.000373	0.00178	CcSEcCtD
Fesoterodine—Nausea—Diclofenamide—glaucoma	0.000372	0.00178	CcSEcCtD
Fesoterodine—Dry mouth—Travoprost—glaucoma	0.000372	0.00178	CcSEcCtD
Fesoterodine—Cough—Pilocarpine—glaucoma	0.00037	0.00177	CcSEcCtD
Fesoterodine—Dizziness—Latanoprost—glaucoma	0.00037	0.00177	CcSEcCtD
Fesoterodine—Confusional state—Dorzolamide—glaucoma	0.000369	0.00177	CcSEcCtD
Fesoterodine—Feeling abnormal—Apraclonidine—glaucoma	0.000368	0.00176	CcSEcCtD
Fesoterodine—Dry mouth—Brinzolamide—glaucoma	0.000367	0.00176	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Apraclonidine—glaucoma	0.000365	0.00175	CcSEcCtD
Fesoterodine—Abdominal pain upper—Timolol—glaucoma	0.000365	0.00175	CcSEcCtD
Fesoterodine—Rash—Methazolamide—glaucoma	0.000364	0.00174	CcSEcCtD
Fesoterodine—Dermatitis—Methazolamide—glaucoma	0.000364	0.00174	CcSEcCtD
Fesoterodine—Eye disorder—Clonidine—glaucoma	0.000364	0.00174	CcSEcCtD
Fesoterodine—Nausea—Carbachol—glaucoma	0.000364	0.00174	CcSEcCtD
Fesoterodine—Infection—Travoprost—glaucoma	0.000362	0.00173	CcSEcCtD
Fesoterodine—Headache—Methazolamide—glaucoma	0.000362	0.00173	CcSEcCtD
Fesoterodine—Cardiac disorder—Clonidine—glaucoma	0.000361	0.00173	CcSEcCtD
Fesoterodine—Chest pain—Pilocarpine—glaucoma	0.000361	0.00173	CcSEcCtD
Fesoterodine—Nausea—Levobunolol—glaucoma	0.000358	0.00171	CcSEcCtD
Fesoterodine—Infection—Brinzolamide—glaucoma	0.000358	0.00171	CcSEcCtD
Fesoterodine—Nervous system disorder—Travoprost—glaucoma	0.000358	0.00171	CcSEcCtD
Fesoterodine—Tachycardia—Travoprost—glaucoma	0.000356	0.0017	CcSEcCtD
Fesoterodine—Somnolence—Acetazolamide—glaucoma	0.000355	0.0017	CcSEcCtD
Fesoterodine—Skin disorder—Travoprost—glaucoma	0.000354	0.00169	CcSEcCtD
Fesoterodine—Abdominal pain—Apraclonidine—glaucoma	0.000353	0.00169	CcSEcCtD
Fesoterodine—Nervous system disorder—Brinzolamide—glaucoma	0.000353	0.00169	CcSEcCtD
Fesoterodine—Rash—Latanoprost—glaucoma	0.000352	0.00168	CcSEcCtD
Fesoterodine—Dermatitis—Latanoprost—glaucoma	0.000352	0.00168	CcSEcCtD
Fesoterodine—Dyspepsia—Acetazolamide—glaucoma	0.000352	0.00168	CcSEcCtD
Fesoterodine—Tachycardia—Brinzolamide—glaucoma	0.000351	0.00168	CcSEcCtD
Fesoterodine—Mediastinal disorder—Clonidine—glaucoma	0.000351	0.00168	CcSEcCtD
Fesoterodine—Headache—Latanoprost—glaucoma	0.00035	0.00167	CcSEcCtD
Fesoterodine—Skin disorder—Brinzolamide—glaucoma	0.00035	0.00167	CcSEcCtD
Fesoterodine—Confusional state—Pilocarpine—glaucoma	0.000349	0.00167	CcSEcCtD
Fesoterodine—Insomnia—Brimonidine—glaucoma	0.000347	0.00166	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000345	0.00165	CcSEcCtD
Fesoterodine—Fatigue—Acetazolamide—glaucoma	0.000345	0.00165	CcSEcCtD
Fesoterodine—Infection—Pilocarpine—glaucoma	0.000344	0.00164	CcSEcCtD
Fesoterodine—Nausea—Methazolamide—glaucoma	0.000343	0.00164	CcSEcCtD
Fesoterodine—Somnolence—Brimonidine—glaucoma	0.000341	0.00163	CcSEcCtD
Fesoterodine—Mental disorder—Clonidine—glaucoma	0.000341	0.00163	CcSEcCtD
Fesoterodine—Tachycardia—Pilocarpine—glaucoma	0.000338	0.00162	CcSEcCtD
Fesoterodine—Dyspepsia—Brimonidine—glaucoma	0.000338	0.00161	CcSEcCtD
Fesoterodine—Angina pectoris—Timolol—glaucoma	0.000337	0.00161	CcSEcCtD
Fesoterodine—Insomnia—Dorzolamide—glaucoma	0.000331	0.00158	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000331	0.00158	CcSEcCtD
Fesoterodine—Fatigue—Brimonidine—glaucoma	0.000331	0.00158	CcSEcCtD
Fesoterodine—Feeling abnormal—Acetazolamide—glaucoma	0.000329	0.00157	CcSEcCtD
Fesoterodine—Hypersensitivity—Apraclonidine—glaucoma	0.000329	0.00157	CcSEcCtD
Fesoterodine—Insomnia—Brinzolamide—glaucoma	0.000326	0.00156	CcSEcCtD
Fesoterodine—Somnolence—Dorzolamide—glaucoma	0.000326	0.00156	CcSEcCtD
Fesoterodine—Dysuria—Timolol—glaucoma	0.000323	0.00155	CcSEcCtD
Fesoterodine—Dyspepsia—Dorzolamide—glaucoma	0.000322	0.00154	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Timolol—glaucoma	0.000321	0.00154	CcSEcCtD
Fesoterodine—Dyspepsia—Travoprost—glaucoma	0.000321	0.00154	CcSEcCtD
Fesoterodine—Asthenia—Apraclonidine—glaucoma	0.000321	0.00153	CcSEcCtD
Fesoterodine—Somnolence—Brinzolamide—glaucoma	0.00032	0.00153	CcSEcCtD
Fesoterodine—Vision blurred—Clonidine—glaucoma	0.000319	0.00153	CcSEcCtD
Fesoterodine—Urticaria—Acetazolamide—glaucoma	0.000317	0.00152	CcSEcCtD
Fesoterodine—Dyspepsia—Brinzolamide—glaucoma	0.000317	0.00152	CcSEcCtD
Fesoterodine—Eye disorder—Betaxolol—glaucoma	0.000317	0.00151	CcSEcCtD
Fesoterodine—Pruritus—Apraclonidine—glaucoma	0.000316	0.00151	CcSEcCtD
Fesoterodine—Fatigue—Dorzolamide—glaucoma	0.000316	0.00151	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Travoprost—glaucoma	0.000315	0.00151	CcSEcCtD
Fesoterodine—Fatigue—Travoprost—glaucoma	0.000314	0.0015	CcSEcCtD
Fesoterodine—Cardiac disorder—Betaxolol—glaucoma	0.000314	0.0015	CcSEcCtD
Fesoterodine—Insomnia—Pilocarpine—glaucoma	0.000313	0.0015	CcSEcCtD
Fesoterodine—Constipation—Travoprost—glaucoma	0.000312	0.00149	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000311	0.00149	CcSEcCtD
Fesoterodine—Asthenia—Bimatoprost—glaucoma	0.000311	0.00149	CcSEcCtD
Fesoterodine—Fatigue—Brinzolamide—glaucoma	0.00031	0.00148	CcSEcCtD
Fesoterodine—Angioedema—Clonidine—glaucoma	0.000309	0.00148	CcSEcCtD
Fesoterodine—Somnolence—Pilocarpine—glaucoma	0.000308	0.00147	CcSEcCtD
Fesoterodine—Pruritus—Bimatoprost—glaucoma	0.000306	0.00147	CcSEcCtD
Fesoterodine—Diarrhoea—Apraclonidine—glaucoma	0.000306	0.00146	CcSEcCtD
Fesoterodine—Mediastinal disorder—Betaxolol—glaucoma	0.000305	0.00146	CcSEcCtD
Fesoterodine—Dyspepsia—Pilocarpine—glaucoma	0.000305	0.00146	CcSEcCtD
Fesoterodine—Feeling abnormal—Dorzolamide—glaucoma	0.000302	0.00144	CcSEcCtD
Fesoterodine—Feeling abnormal—Travoprost—glaucoma	0.000301	0.00144	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dorzolamide—glaucoma	0.0003	0.00143	CcSEcCtD
Fesoterodine—Palpitations—Clonidine—glaucoma	0.000299	0.00143	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000299	0.00143	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Travoprost—glaucoma	0.000298	0.00143	CcSEcCtD
Fesoterodine—Feeling abnormal—Brinzolamide—glaucoma	0.000297	0.00142	CcSEcCtD
Fesoterodine—Mental disorder—Betaxolol—glaucoma	0.000297	0.00142	CcSEcCtD
Fesoterodine—Constipation—Pilocarpine—glaucoma	0.000296	0.00142	CcSEcCtD
Fesoterodine—Cough—Clonidine—glaucoma	0.000296	0.00141	CcSEcCtD
Fesoterodine—Dizziness—Apraclonidine—glaucoma	0.000295	0.00141	CcSEcCtD
Fesoterodine—Urticaria—Dorzolamide—glaucoma	0.000291	0.00139	CcSEcCtD
Fesoterodine—Abdominal pain—Dorzolamide—glaucoma	0.00029	0.00138	CcSEcCtD
Fesoterodine—Dysgeusia—Betaxolol—glaucoma	0.000289	0.00138	CcSEcCtD
Fesoterodine—Chest pain—Clonidine—glaucoma	0.000288	0.00138	CcSEcCtD
Fesoterodine—Abdominal pain—Travoprost—glaucoma	0.000288	0.00138	CcSEcCtD
Fesoterodine—Asthenia—Acetazolamide—glaucoma	0.000287	0.00137	CcSEcCtD
Fesoterodine—Dizziness—Bimatoprost—glaucoma	0.000286	0.00137	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000286	0.00137	CcSEcCtD
Fesoterodine—Urticaria—Brinzolamide—glaucoma	0.000286	0.00137	CcSEcCtD
Fesoterodine—Feeling abnormal—Pilocarpine—glaucoma	0.000285	0.00136	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000283	0.00135	CcSEcCtD
Fesoterodine—Hypersensitivity—Brimonidine—glaucoma	0.000283	0.00135	CcSEcCtD
Fesoterodine—Dry mouth—Clonidine—glaucoma	0.000282	0.00135	CcSEcCtD
Fesoterodine—Dermatitis—Apraclonidine—glaucoma	0.000281	0.00135	CcSEcCtD
Fesoterodine—Headache—Apraclonidine—glaucoma	0.00028	0.00134	CcSEcCtD
Fesoterodine—Confusional state—Clonidine—glaucoma	0.000279	0.00133	CcSEcCtD
Fesoterodine—Vision blurred—Betaxolol—glaucoma	0.000278	0.00133	CcSEcCtD
Fesoterodine—Asthenia—Brimonidine—glaucoma	0.000275	0.00132	CcSEcCtD
Fesoterodine—Infection—Clonidine—glaucoma	0.000275	0.00131	CcSEcCtD
Fesoterodine—Abdominal pain—Pilocarpine—glaucoma	0.000274	0.00131	CcSEcCtD
Fesoterodine—Diarrhoea—Acetazolamide—glaucoma	0.000273	0.00131	CcSEcCtD
Fesoterodine—Rash—Bimatoprost—glaucoma	0.000273	0.00131	CcSEcCtD
Fesoterodine—Dermatitis—Bimatoprost—glaucoma	0.000273	0.0013	CcSEcCtD
Fesoterodine—Oedema peripheral—Timolol—glaucoma	0.000273	0.0013	CcSEcCtD
Fesoterodine—Pruritus—Brimonidine—glaucoma	0.000271	0.0013	CcSEcCtD
Fesoterodine—Headache—Bimatoprost—glaucoma	0.000271	0.0013	CcSEcCtD
Fesoterodine—Nervous system disorder—Clonidine—glaucoma	0.000271	0.0013	CcSEcCtD
Fesoterodine—Hypersensitivity—Dorzolamide—glaucoma	0.00027	0.00129	CcSEcCtD
Fesoterodine—Tachycardia—Clonidine—glaucoma	0.00027	0.00129	CcSEcCtD
Fesoterodine—Hypersensitivity—Travoprost—glaucoma	0.000269	0.00128	CcSEcCtD
Fesoterodine—Skin disorder—Clonidine—glaucoma	0.000268	0.00128	CcSEcCtD
Fesoterodine—Nausea—Apraclonidine—glaucoma	0.000265	0.00127	CcSEcCtD
Fesoterodine—Hypersensitivity—Brinzolamide—glaucoma	0.000265	0.00127	CcSEcCtD
Fesoterodine—Vertigo—Betaxolol—glaucoma	0.000265	0.00127	CcSEcCtD
Fesoterodine—Dizziness—Acetazolamide—glaucoma	0.000264	0.00126	CcSEcCtD
Fesoterodine—Asthenia—Dorzolamide—glaucoma	0.000263	0.00126	CcSEcCtD
Fesoterodine—Asthenia—Travoprost—glaucoma	0.000262	0.00125	CcSEcCtD
Fesoterodine—Palpitations—Betaxolol—glaucoma	0.000261	0.00125	CcSEcCtD
Fesoterodine—Pruritus—Dorzolamide—glaucoma	0.000259	0.00124	CcSEcCtD
Fesoterodine—Eye disorder—Timolol—glaucoma	0.000259	0.00124	CcSEcCtD
Fesoterodine—Asthenia—Brinzolamide—glaucoma	0.000258	0.00124	CcSEcCtD
Fesoterodine—Pruritus—Travoprost—glaucoma	0.000258	0.00123	CcSEcCtD
Fesoterodine—Cough—Betaxolol—glaucoma	0.000257	0.00123	CcSEcCtD
Fesoterodine—Nausea—Bimatoprost—glaucoma	0.000257	0.00123	CcSEcCtD
Fesoterodine—Cardiac disorder—Timolol—glaucoma	0.000257	0.00123	CcSEcCtD
Fesoterodine—Hypersensitivity—Pilocarpine—glaucoma	0.000255	0.00122	CcSEcCtD
Fesoterodine—Pruritus—Brinzolamide—glaucoma	0.000255	0.00122	CcSEcCtD
Fesoterodine—Dizziness—Brimonidine—glaucoma	0.000254	0.00121	CcSEcCtD
Fesoterodine—Chest pain—Betaxolol—glaucoma	0.000251	0.0012	CcSEcCtD
Fesoterodine—Diarrhoea—Dorzolamide—glaucoma	0.000251	0.0012	CcSEcCtD
Fesoterodine—Headache—Acetazolamide—glaucoma	0.00025	0.0012	CcSEcCtD
Fesoterodine—Insomnia—Clonidine—glaucoma	0.00025	0.0012	CcSEcCtD
Fesoterodine—Diarrhoea—Travoprost—glaucoma	0.00025	0.00119	CcSEcCtD
Fesoterodine—Mediastinal disorder—Timolol—glaucoma	0.000249	0.00119	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000249	0.00119	CcSEcCtD
Fesoterodine—Asthenia—Pilocarpine—glaucoma	0.000248	0.00119	CcSEcCtD
Fesoterodine—Diarrhoea—Brinzolamide—glaucoma	0.000246	0.00118	CcSEcCtD
Fesoterodine—Somnolence—Clonidine—glaucoma	0.000246	0.00117	CcSEcCtD
Fesoterodine—Dry mouth—Betaxolol—glaucoma	0.000246	0.00117	CcSEcCtD
Fesoterodine—Pruritus—Pilocarpine—glaucoma	0.000245	0.00117	CcSEcCtD
Fesoterodine—Confusional state—Betaxolol—glaucoma	0.000243	0.00116	CcSEcCtD
Fesoterodine—Mental disorder—Timolol—glaucoma	0.000242	0.00116	CcSEcCtD
Fesoterodine—Dizziness—Dorzolamide—glaucoma	0.000242	0.00116	CcSEcCtD
Fesoterodine—Rash—Brimonidine—glaucoma	0.000242	0.00116	CcSEcCtD
Fesoterodine—Dermatitis—Brimonidine—glaucoma	0.000242	0.00116	CcSEcCtD
Fesoterodine—Dizziness—Travoprost—glaucoma	0.000241	0.00115	CcSEcCtD
Fesoterodine—Headache—Brimonidine—glaucoma	0.00024	0.00115	CcSEcCtD
Fesoterodine—Infection—Betaxolol—glaucoma	0.000239	0.00114	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Clonidine—glaucoma	0.000239	0.00114	CcSEcCtD
Fesoterodine—Fatigue—Clonidine—glaucoma	0.000238	0.00114	CcSEcCtD
Fesoterodine—Dizziness—Brinzolamide—glaucoma	0.000238	0.00114	CcSEcCtD
Fesoterodine—Nausea—Acetazolamide—glaucoma	0.000237	0.00114	CcSEcCtD
Fesoterodine—Diarrhoea—Pilocarpine—glaucoma	0.000237	0.00113	CcSEcCtD
Fesoterodine—Constipation—Clonidine—glaucoma	0.000236	0.00113	CcSEcCtD
Fesoterodine—Nervous system disorder—Betaxolol—glaucoma	0.000236	0.00113	CcSEcCtD
Fesoterodine—Dysgeusia—Timolol—glaucoma	0.000236	0.00113	CcSEcCtD
Fesoterodine—Tachycardia—Betaxolol—glaucoma	0.000235	0.00112	CcSEcCtD
Fesoterodine—Skin disorder—Betaxolol—glaucoma	0.000234	0.00112	CcSEcCtD
Fesoterodine—Rash—Dorzolamide—glaucoma	0.000231	0.0011	CcSEcCtD
Fesoterodine—Dermatitis—Dorzolamide—glaucoma	0.000231	0.0011	CcSEcCtD
Fesoterodine—Rash—Travoprost—glaucoma	0.00023	0.0011	CcSEcCtD
Fesoterodine—Dermatitis—Travoprost—glaucoma	0.00023	0.0011	CcSEcCtD
Fesoterodine—Headache—Dorzolamide—glaucoma	0.000229	0.0011	CcSEcCtD
Fesoterodine—Dizziness—Pilocarpine—glaucoma	0.000229	0.00109	CcSEcCtD
Fesoterodine—Headache—Travoprost—glaucoma	0.000228	0.00109	CcSEcCtD
Fesoterodine—Nausea—Brimonidine—glaucoma	0.000228	0.00109	CcSEcCtD
Fesoterodine—Feeling abnormal—Clonidine—glaucoma	0.000228	0.00109	CcSEcCtD
Fesoterodine—Rash—Brinzolamide—glaucoma	0.000227	0.00109	CcSEcCtD
Fesoterodine—Vision blurred—Timolol—glaucoma	0.000227	0.00109	CcSEcCtD
Fesoterodine—Dermatitis—Brinzolamide—glaucoma	0.000227	0.00108	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Clonidine—glaucoma	0.000226	0.00108	CcSEcCtD
Fesoterodine—Headache—Brinzolamide—glaucoma	0.000226	0.00108	CcSEcCtD
Fesoterodine—Angioedema—Timolol—glaucoma	0.00022	0.00105	CcSEcCtD
Fesoterodine—Urticaria—Clonidine—glaucoma	0.00022	0.00105	CcSEcCtD
Fesoterodine—Abdominal pain—Clonidine—glaucoma	0.000219	0.00104	CcSEcCtD
Fesoterodine—Rash—Pilocarpine—glaucoma	0.000218	0.00104	CcSEcCtD
Fesoterodine—Dermatitis—Pilocarpine—glaucoma	0.000218	0.00104	CcSEcCtD
Fesoterodine—Insomnia—Betaxolol—glaucoma	0.000218	0.00104	CcSEcCtD
Fesoterodine—Nausea—Dorzolamide—glaucoma	0.000218	0.00104	CcSEcCtD
Fesoterodine—Headache—Pilocarpine—glaucoma	0.000217	0.00104	CcSEcCtD
Fesoterodine—Nausea—Travoprost—glaucoma	0.000217	0.00104	CcSEcCtD
Fesoterodine—Vertigo—Timolol—glaucoma	0.000216	0.00103	CcSEcCtD
Fesoterodine—Nausea—Brinzolamide—glaucoma	0.000214	0.00102	CcSEcCtD
Fesoterodine—Palpitations—Timolol—glaucoma	0.000213	0.00102	CcSEcCtD
Fesoterodine—Dyspepsia—Betaxolol—glaucoma	0.000212	0.00101	CcSEcCtD
Fesoterodine—Cough—Timolol—glaucoma	0.00021	0.00101	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000208	0.000993	CcSEcCtD
Fesoterodine—Fatigue—Betaxolol—glaucoma	0.000207	0.000992	CcSEcCtD
Fesoterodine—Constipation—Betaxolol—glaucoma	0.000206	0.000984	CcSEcCtD
Fesoterodine—Nausea—Pilocarpine—glaucoma	0.000206	0.000983	CcSEcCtD
Fesoterodine—Chest pain—Timolol—glaucoma	0.000205	0.000981	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000204	0.000974	CcSEcCtD
Fesoterodine—Hypersensitivity—Clonidine—glaucoma	0.000204	0.000974	CcSEcCtD
Fesoterodine—Dry mouth—Timolol—glaucoma	0.000201	0.000959	CcSEcCtD
Fesoterodine—Asthenia—Clonidine—glaucoma	0.000198	0.000948	CcSEcCtD
Fesoterodine—Feeling abnormal—Betaxolol—glaucoma	0.000198	0.000948	CcSEcCtD
Fesoterodine—Confusional state—Timolol—glaucoma	0.000198	0.000948	CcSEcCtD
Fesoterodine—Pruritus—Clonidine—glaucoma	0.000196	0.000935	CcSEcCtD
Fesoterodine—Infection—Timolol—glaucoma	0.000195	0.000934	CcSEcCtD
Fesoterodine—Nervous system disorder—Timolol—glaucoma	0.000193	0.000922	CcSEcCtD
Fesoterodine—Urticaria—Betaxolol—glaucoma	0.000191	0.000914	CcSEcCtD
Fesoterodine—Skin disorder—Timolol—glaucoma	0.000191	0.000913	CcSEcCtD
Fesoterodine—Diarrhoea—Clonidine—glaucoma	0.000189	0.000904	CcSEcCtD
Fesoterodine—Dizziness—Clonidine—glaucoma	0.000183	0.000874	CcSEcCtD
Fesoterodine—Insomnia—Timolol—glaucoma	0.000178	0.00085	CcSEcCtD
Fesoterodine—Hypersensitivity—Betaxolol—glaucoma	0.000177	0.000848	CcSEcCtD
Fesoterodine—Somnolence—Timolol—glaucoma	0.000175	0.000836	CcSEcCtD
Fesoterodine—Rash—Clonidine—glaucoma	0.000174	0.000833	CcSEcCtD
Fesoterodine—Dermatitis—Clonidine—glaucoma	0.000174	0.000833	CcSEcCtD
Fesoterodine—Headache—Clonidine—glaucoma	0.000173	0.000828	CcSEcCtD
Fesoterodine—Dyspepsia—Timolol—glaucoma	0.000173	0.000827	CcSEcCtD
Fesoterodine—Asthenia—Betaxolol—glaucoma	0.000173	0.000826	CcSEcCtD
Fesoterodine—Pruritus—Betaxolol—glaucoma	0.00017	0.000814	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Timolol—glaucoma	0.00017	0.000812	CcSEcCtD
Fesoterodine—Fatigue—Timolol—glaucoma	0.00017	0.00081	CcSEcCtD
Fesoterodine—Diarrhoea—Betaxolol—glaucoma	0.000165	0.000787	CcSEcCtD
Fesoterodine—Nausea—Clonidine—glaucoma	0.000164	0.000785	CcSEcCtD
Fesoterodine—Feeling abnormal—Timolol—glaucoma	0.000162	0.000775	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Timolol—glaucoma	0.000161	0.000769	CcSEcCtD
Fesoterodine—Dizziness—Betaxolol—glaucoma	0.000159	0.000761	CcSEcCtD
Fesoterodine—Urticaria—Timolol—glaucoma	0.000156	0.000747	CcSEcCtD
Fesoterodine—Abdominal pain—Timolol—glaucoma	0.000155	0.000743	CcSEcCtD
Fesoterodine—Rash—Betaxolol—glaucoma	0.000152	0.000725	CcSEcCtD
Fesoterodine—Dermatitis—Betaxolol—glaucoma	0.000152	0.000725	CcSEcCtD
Fesoterodine—Headache—Betaxolol—glaucoma	0.000151	0.000721	CcSEcCtD
Fesoterodine—Hypersensitivity—Timolol—glaucoma	0.000145	0.000693	CcSEcCtD
Fesoterodine—Nausea—Betaxolol—glaucoma	0.000143	0.000683	CcSEcCtD
Fesoterodine—Asthenia—Timolol—glaucoma	0.000141	0.000674	CcSEcCtD
Fesoterodine—Pruritus—Timolol—glaucoma	0.000139	0.000665	CcSEcCtD
Fesoterodine—Diarrhoea—Timolol—glaucoma	0.000135	0.000643	CcSEcCtD
Fesoterodine—Dizziness—Timolol—glaucoma	0.00013	0.000622	CcSEcCtD
Fesoterodine—Rash—Timolol—glaucoma	0.000124	0.000593	CcSEcCtD
Fesoterodine—Dermatitis—Timolol—glaucoma	0.000124	0.000592	CcSEcCtD
Fesoterodine—Headache—Timolol—glaucoma	0.000123	0.000589	CcSEcCtD
Fesoterodine—Nausea—Timolol—glaucoma	0.000117	0.000558	CcSEcCtD
Fesoterodine—CHRM1—Signaling by GPCR—PTGFR—glaucoma	2.37e-05	0.00202	CbGpPWpGaD
Fesoterodine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.37e-05	0.00202	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PTGFR—glaucoma	2.36e-05	0.00201	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PTGFR—glaucoma	2.34e-05	0.00199	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—SMO—glaucoma	2.33e-05	0.00198	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—SMO—glaucoma	2.32e-05	0.00198	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—OPN4—glaucoma	2.31e-05	0.00196	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—SMO—glaucoma	2.3e-05	0.00196	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—EDN1—glaucoma	2.28e-05	0.00194	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LRP12—glaucoma	2.24e-05	0.00191	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CA5A—glaucoma	2.24e-05	0.00191	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NARFL—glaucoma	2.24e-05	0.00191	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LRP12—glaucoma	2.24e-05	0.00191	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LRP12—glaucoma	2.21e-05	0.00189	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—OPN4—glaucoma	2.21e-05	0.00188	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—C3—glaucoma	2.19e-05	0.00186	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—EDN1—glaucoma	2.18e-05	0.00186	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HEYL—glaucoma	2.14e-05	0.00183	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.14e-05	0.00182	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CA5A—glaucoma	2.11e-05	0.0018	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NARFL—glaucoma	2.11e-05	0.0018	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PTGFR—glaucoma	2.08e-05	0.00177	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HEYL—glaucoma	2.05e-05	0.00175	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.02e-05	0.00172	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.01e-05	0.00171	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.99e-05	0.0017	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—C3—glaucoma	1.99e-05	0.00169	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PTGFR—glaucoma	1.99e-05	0.00169	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.97e-05	0.00168	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.97e-05	0.00168	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.96e-05	0.00167	CbGpPWpGaD
Fesoterodine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	1.94e-05	0.00166	CbGpPWpGaD
Fesoterodine—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.92e-05	0.00163	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—C3—glaucoma	1.9e-05	0.00162	CbGpPWpGaD
Fesoterodine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.89e-05	0.00161	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.83e-05	0.00156	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—SMO—glaucoma	1.77e-05	0.00151	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.76e-05	0.0015	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.76e-05	0.0015	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.74e-05	0.00148	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CA1—glaucoma	1.72e-05	0.00147	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—SMO—glaucoma	1.7e-05	0.00145	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.68e-05	0.00143	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.68e-05	0.00143	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CTSA—glaucoma	1.67e-05	0.00142	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RPTOR—glaucoma	1.62e-05	0.00138	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CA2—glaucoma	1.58e-05	0.00134	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NCK2—glaucoma	1.57e-05	0.00134	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.57e-05	0.00134	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RPTOR—glaucoma	1.56e-05	0.00133	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—OPN4—glaucoma	1.55e-05	0.00132	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—OPN4—glaucoma	1.55e-05	0.00132	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.55e-05	0.00132	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—EDN1—glaucoma	1.54e-05	0.00131	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—OPN4—glaucoma	1.53e-05	0.00131	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—EDN1—glaucoma	1.53e-05	0.0013	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.53e-05	0.0013	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—EDN1—glaucoma	1.52e-05	0.00129	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NCK2—glaucoma	1.51e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HEYL—glaucoma	1.45e-05	0.00123	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—TNF—glaucoma	1.44e-05	0.00123	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HEYL—glaucoma	1.44e-05	0.00123	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.43e-05	0.00122	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HEYL—glaucoma	1.43e-05	0.00122	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.4e-05	0.00119	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.4e-05	0.00119	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.38e-05	0.00118	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA5A—glaucoma	1.38e-05	0.00118	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NARFL—glaucoma	1.38e-05	0.00118	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—C3—glaucoma	1.34e-05	0.00114	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.34e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HDAC9—glaucoma	1.34e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—C3—glaucoma	1.34e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—C3—glaucoma	1.32e-05	0.00113	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.31e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—EDN1—glaucoma	1.29e-05	0.0011	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HDAC9—glaucoma	1.28e-05	0.00109	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.25e-05	0.00107	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.24e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—EDN1—glaucoma	1.23e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—SMO—glaucoma	1.2e-05	0.00102	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—SMO—glaucoma	1.19e-05	0.00101	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—SMO—glaucoma	1.18e-05	0.00101	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—EDN1—glaucoma	1.17e-05	0.000996	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—C3—glaucoma	1.12e-05	0.000958	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EDN1—glaucoma	1.12e-05	0.000953	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—TXN—glaucoma	1.11e-05	0.000946	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RPTOR—glaucoma	1.1e-05	0.000933	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CA1—glaucoma	1.09e-05	0.000932	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RPTOR—glaucoma	1.09e-05	0.00093	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RPTOR—glaucoma	1.08e-05	0.000921	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—C3—glaucoma	1.08e-05	0.000917	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NCK2—glaucoma	1.06e-05	0.000904	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CTSA—glaucoma	1.06e-05	0.000902	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NCK2—glaucoma	1.06e-05	0.000901	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.06e-05	0.000899	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NCK2—glaucoma	1.05e-05	0.000892	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SMO—glaucoma	1.05e-05	0.000892	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CA1—glaucoma	1.03e-05	0.000878	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—C3—glaucoma	1.02e-05	0.00087	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SMO—glaucoma	1e-05	0.000854	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CA2—glaucoma	1e-05	0.000852	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	9.99e-06	0.000851	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CTSA—glaucoma	9.98e-06	0.00085	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—C3—glaucoma	9.78e-06	0.000833	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NTRK2—glaucoma	9.58e-06	0.000816	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—TP53—glaucoma	9.53e-06	0.000812	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CA2—glaucoma	9.42e-06	0.000803	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NTRK2—glaucoma	9.17e-06	0.000781	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HDAC9—glaucoma	9.02e-06	0.000769	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HDAC9—glaucoma	8.99e-06	0.000766	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HDAC9—glaucoma	8.91e-06	0.000759	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—EDN1—glaucoma	8.68e-06	0.000739	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—EDN1—glaucoma	8.65e-06	0.000737	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTT1—glaucoma	8.61e-06	0.000734	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—EDN1—glaucoma	8.57e-06	0.00073	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	8.31e-06	0.000708	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NGFR—glaucoma	8.22e-06	0.0007	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EDN1—glaucoma	7.88e-06	0.000671	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NGFR—glaucoma	7.87e-06	0.00067	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EDN1—glaucoma	7.85e-06	0.000669	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NTRK1—glaucoma	7.81e-06	0.000665	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EDN1—glaucoma	7.78e-06	0.000663	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—C3—glaucoma	7.58e-06	0.000646	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—C3—glaucoma	7.56e-06	0.000644	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—C3—glaucoma	7.48e-06	0.000637	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NTRK1—glaucoma	7.48e-06	0.000637	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CDKN2B—glaucoma	7.19e-06	0.000613	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7.12e-06	0.000607	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SMO—glaucoma	7.06e-06	0.000601	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TXN—glaucoma	7.05e-06	0.0006	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SMO—glaucoma	7.04e-06	0.0006	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SMO—glaucoma	6.97e-06	0.000594	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EDN1—glaucoma	6.9e-06	0.000588	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CDKN2B—glaucoma	6.89e-06	0.000587	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—C3—glaucoma	6.88e-06	0.000586	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—C3—glaucoma	6.86e-06	0.000585	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ABCA1—glaucoma	6.86e-06	0.000585	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP1B1—glaucoma	6.86e-06	0.000585	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—C3—glaucoma	6.79e-06	0.000579	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA1—glaucoma	6.74e-06	0.000574	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TXN—glaucoma	6.64e-06	0.000566	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EDN1—glaucoma	6.61e-06	0.000563	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CTSA—glaucoma	6.52e-06	0.000556	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NTRK2—glaucoma	6.46e-06	0.00055	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NTRK2—glaucoma	6.44e-06	0.000548	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NTRK2—glaucoma	6.37e-06	0.000543	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NGF—glaucoma	6.34e-06	0.00054	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.28e-06	0.000535	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA2—glaucoma	6.16e-06	0.000525	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NGF—glaucoma	6.07e-06	0.000518	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—C3—glaucoma	6.03e-06	0.000514	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—C3—glaucoma	5.77e-06	0.000492	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APOE—glaucoma	5.61e-06	0.000478	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CAV1—glaucoma	5.56e-06	0.000474	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGFR—glaucoma	5.54e-06	0.000472	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGFR—glaucoma	5.52e-06	0.00047	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTM1—glaucoma	5.48e-06	0.000467	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGFR—glaucoma	5.47e-06	0.000466	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTT1—glaucoma	5.46e-06	0.000465	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APOE—glaucoma	5.38e-06	0.000458	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CAV1—glaucoma	5.33e-06	0.000454	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—FN1—glaucoma	5.29e-06	0.000451	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NTRK1—glaucoma	5.26e-06	0.000448	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NTRK1—glaucoma	5.25e-06	0.000447	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—BAD—glaucoma	5.23e-06	0.000446	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NTRK1—glaucoma	5.2e-06	0.000443	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTT1—glaucoma	5.15e-06	0.000439	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—FN1—glaucoma	5.07e-06	0.000432	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—BAD—glaucoma	5.01e-06	0.000427	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	4.85e-06	0.000413	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MTHFR—glaucoma	4.85e-06	0.000413	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	4.84e-06	0.000412	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	4.79e-06	0.000408	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EDN1—glaucoma	4.65e-06	0.000397	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EDN1—glaucoma	4.64e-06	0.000395	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EDN1—glaucoma	4.59e-06	0.000391	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—APOE—glaucoma	4.51e-06	0.000384	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CAV1—glaucoma	4.47e-06	0.000381	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ABCA1—glaucoma	4.35e-06	0.000371	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP1B1—glaucoma	4.35e-06	0.000371	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TXN—glaucoma	4.34e-06	0.00037	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGF—glaucoma	4.28e-06	0.000364	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGF—glaucoma	4.26e-06	0.000363	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGF—glaucoma	4.22e-06	0.00036	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOS3—glaucoma	4.21e-06	0.000358	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCA1—glaucoma	4.1e-06	0.000349	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP1B1—glaucoma	4.1e-06	0.000349	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—C3—glaucoma	4.07e-06	0.000346	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—C3—glaucoma	4.05e-06	0.000345	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOS3—glaucoma	4.03e-06	0.000343	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—C3—glaucoma	4.01e-06	0.000342	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—glaucoma	3.79e-06	0.000323	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—glaucoma	3.77e-06	0.000321	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CAV1—glaucoma	3.75e-06	0.00032	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CAV1—glaucoma	3.74e-06	0.000319	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—glaucoma	3.74e-06	0.000318	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CAV1—glaucoma	3.7e-06	0.000315	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	3.64e-06	0.00031	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FN1—glaucoma	3.57e-06	0.000304	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FN1—glaucoma	3.56e-06	0.000303	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—BAD—glaucoma	3.53e-06	0.000301	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FN1—glaucoma	3.52e-06	0.0003	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—BAD—glaucoma	3.52e-06	0.0003	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	3.49e-06	0.000297	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—BAD—glaucoma	3.48e-06	0.000297	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTM1—glaucoma	3.48e-06	0.000296	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—glaucoma	3.38e-06	0.000288	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—glaucoma	3.37e-06	0.000287	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTT1—glaucoma	3.37e-06	0.000287	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTM1—glaucoma	3.28e-06	0.000279	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—glaucoma	3.23e-06	0.000275	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—glaucoma	3.09e-06	0.000263	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—glaucoma	3.08e-06	0.000262	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—glaucoma	3.03e-06	0.000258	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.9e-06	0.000247	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—glaucoma	2.9e-06	0.000247	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—glaucoma	2.86e-06	0.000244	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CAV1—glaucoma	2.84e-06	0.000242	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—glaucoma	2.84e-06	0.000242	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—glaucoma	2.83e-06	0.000241	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—glaucoma	2.8e-06	0.000239	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—glaucoma	2.7e-06	0.00023	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP1B1—glaucoma	2.68e-06	0.000229	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCA1—glaucoma	2.68e-06	0.000229	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CAV1—glaucoma	2.67e-06	0.000228	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	2.46e-06	0.000209	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	2.45e-06	0.000209	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	2.43e-06	0.000207	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—glaucoma	2.29e-06	0.000195	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—glaucoma	2.28e-06	0.000194	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—glaucoma	2.27e-06	0.000193	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—glaucoma	2.25e-06	0.000191	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—glaucoma	2.19e-06	0.000187	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—glaucoma	2.15e-06	0.000183	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTM1—glaucoma	2.14e-06	0.000183	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—glaucoma	2.04e-06	0.000174	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—glaucoma	2.04e-06	0.000174	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—glaucoma	2.02e-06	0.000172	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.02e-06	0.000172	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—glaucoma	1.96e-06	0.000167	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—glaucoma	1.89e-06	0.000161	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—glaucoma	1.85e-06	0.000158	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—glaucoma	1.76e-06	0.00015	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CAV1—glaucoma	1.75e-06	0.000149	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—glaucoma	1.54e-06	0.000132	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—glaucoma	1.54e-06	0.000131	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—glaucoma	1.52e-06	0.00013	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—glaucoma	1.32e-06	0.000113	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—glaucoma	1.21e-06	0.000103	CbGpPWpGaD
